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Background
In Uganda artemether-lumefantrine (AL) is the first-line
treatment for uncomplicated falciparum malaria. During a
longitudinal study (SIMI project) investigating the
dynamics of intestinal schistosomiasis and malaria in
Ugandan lakeshore communities, a consistently high pre-
valence of malaria was found in young children (including
many mixed infections of Plasmodium falciparum with
P. malariae and/or P. ovale sspp), despite use of AL for
home-based management of malaria. As a first step to
gather evidence on the effectiveness of AL in this setting, a
community-based observational study was initiated in an
area of intense malaria transmission.
Materials and methods
The study was carried out in Bukoba village, Mayuge Dis-
trict. A group of children (W = 163) within the SIMI
cohort was selected on the basis of a positive First
Response rapid diagnostic test (RDT) result and micro-
scopy-confirmed malaria. Children were actively followed
up 7 and 17 days after baseline. Individuals who were
RDT-positive on Day 17 were also followed up on Day 24.
At each time-point, a blood smear archive was made and
microscopy was performed two-three days after samples
were taken. In addition, blood spots were collected onto
Whatmann 3MM filter paper. Treatment decisions in the
field were based on RDT results. All study participants
were treated with AL at baseline. Children who were
malaria positive by OptiMAL RDT on Day 7 were
retreated with AL and those who were malaria positive on
Day 17 were treated with oral quinine. All children were
tested for Schistosoma mansoni and soil-transmitted hel-
minth infections at baseline and treated with praziquantel
and albendazole.
Genomic DNA was extracted from blood spots using
chelex and real-time PCR diagnosis of Plasmodium species
was performed. To distinguish between recrudescent and
new infections, genotyping of merozoite surface proteins
(msp1 and msp2) and glutamate-rich protein (glurp) was
carried out.
Results
Forty children (26.3%) were microscopy-positive for
malaria on Day 7 and 33 (21.3%) on Day 17. After geno-
typing, 33 (21.9%) and 17 (11.7%) children were shown
to have recrudescent infections on Days 7 and 17,
respectively. Of the 28 children who had received two
consecutive AL treatments, 11 were microscopy positive
on Day 17.
Multi-species Plasmodium infections were common,
with 41.1% of children positive for P. falciparum/
P. malariae, 9.2% positive for P. falciparum/P. ovale
sspp. and 8.0% for all three species at baseline. By real-
time PCR 39.9% of those children infected with falci-
parum malaria at baseline were P. falciparum positive at
Day 17 and 9.2% of those who were infected with
P. malariae at baseline were P. malariae positive at Day
17. On Day 24, after two or three consecutive anti-
malarial treatments, 10 children were infected with
P. falciparum and two with P. malariae.
Conclusions
Our results suggest that AL may not be as effective as pre-
viously thought for treatment of malaria at a community-
based level in Uganda and that further more formalised
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efficacy studies of this drug in high transmission settings
are required, particularly in areas where mixed-species
malaria infections are common and where mass adminis-
tration of anthelminthic drugs is being carried out.
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